Introduction

Submitting a 510(k) to the U.S. Food and Drug Administration is a significant milestone for medical device manufacturers. However, many companies assume that once the submission is filed, the review will simply proceed to clearance. In reality, it is very common for the FDA to issue an Additional Information (AI) request during the review process.

An AI request means the FDA reviewer needs clarifications, additional data, or corrections before they can complete the evaluation of your device. While receiving an AI request may feel discouraging, it is a normal part of the regulatory review process. The key is knowing how to prepare for it and respond effectively.

This article explains what AI requests are, why they happen, and how manufacturers can prepare for them to avoid delays in the regulatory pathway.

What Is an FDA Additional Information Request?

During the review of a 510(k) submission, the FDA reviewer evaluates the documentation to determine whether the device is substantially equivalent to a predicate device.

If the reviewer identifies missing information, inconsistencies, or insufficient data, they will issue an Additional Information (AI) request. This request typically includes a list of questions or requests for further documentation.

Common reasons for AI requests include:

• Missing or incomplete performance testing
• Unclear predicate comparison
• Inadequate biocompatibility data
• Insufficient sterilization validation
• Labeling inconsistencies
• Risk management gaps

Manufacturers are usually given 180 days to respond. If the response is not submitted within that time, the submission may be considered withdrawn, requiring a new submission.

Why AI Requests Occur

Understanding why AI requests occur can help manufacturers prepare better submissions.

1. Incomplete Data

Sometimes the submission lacks critical information required for FDA evaluation. For example, performance testing may not cover all relevant scenarios or device specifications.

2. Lack of Clarity

Even if the data is included, the FDA reviewer may find the information unclear or difficult to interpret.

3. Inconsistent Documentation

Differences between sections of the submission can trigger questions. For example, the intended use described in labeling may differ from the description in the device summary.

4. Insufficient Predicate Comparison

A weak comparison with the predicate device can make it difficult for the reviewer to determine substantial equivalence.

Preparing for AI Requests Before Submission

One of the best strategies for handling AI requests is preparation before submission. A well-prepared submission reduces the likelihood of receiving extensive AI questions.

Conduct a Thorough Gap Analysis

Before submitting the 510(k), review the submission against FDA guidance documents and checklists. Identify whether any required data or testing is missing.

Key areas to review include:

• Device description
• Predicate comparison
• Performance testing
• Risk management documentation
• Biocompatibility assessment
• Sterilization validation
• Shelf-life data
• Labeling

A comprehensive gap analysis ensures that all necessary documentation is included.

Align All Sections of the Submission

Consistency is critical. The following sections must align with each other:

• Intended use
• Indications for use
• Device description
• Labeling
• Performance testing

Any inconsistency can trigger questions from the reviewer.

Ensure Testing Is Complete

Many AI requests arise from incomplete or insufficient testing. Manufacturers should confirm that all required tests are completed before submission.

Examples include:

• Electrical safety testing
• Software validation
• Biocompatibility testing
• Mechanical performance testing
• Sterilization validation

Providing complete and well-documented test reports can significantly reduce regulatory questions.

How to Respond to an AI Request Effectively

Receiving an AI request does not mean the submission will be rejected. It simply means the FDA needs additional information to continue the review.

Here are best practices for responding effectively.

1. Carefully Review Each Question

The first step is to thoroughly review the AI request and understand each question.

Break down the request into individual items and determine:

• What information is being requested
• Which department or team can provide the data
• Whether additional testing is required

Creating an internal response plan helps manage the process efficiently.

2. Provide Clear and Structured Responses

When preparing the response document, ensure that the answers are clear, organized, and easy to review.

A common structure includes:

• Restating the FDA question
• Providing a direct response
• Referencing supporting documentation
• Including revised sections if necessary

Avoid vague answers. Every response should be specific and supported by data.

3. Highlight Updated Information

If changes are made to the submission, clearly indicate them in the response.

For example:

• Provide redlined documents showing modifications
• Clearly identify updated sections of the submission
• Reference the page numbers of revised documents

This helps the reviewer quickly identify the changes and evaluate the response efficiently.

4. Maintain Consistency Across Documents

If one section of the submission is updated, verify whether related sections must also be revised.

For example, changes to the device description may require updates in:

• Risk management documentation
• Labeling
• Testing summaries

Consistency across documents prevents follow-up questions.

5. Submit the Response on Time

The FDA allows 180 days to respond to an AI request. However, manufacturers should aim to submit responses as early as possible.

Quick and well-prepared responses help maintain the review timeline and demonstrate regulatory readiness.

Common Mistakes When Responding to AI Requests

Some responses fail to resolve the reviewer’s concerns because of avoidable mistakes.

Common errors include:

• Providing incomplete responses
• Failing to address all questions
• Submitting unclear or poorly structured documents
• Ignoring inconsistencies within the submission
• Delaying the response timeline

Avoiding these mistakes can improve the chances of a successful review.

Final Thoughts

AI requests are a normal part of the regulatory review process and should not be viewed as a failure. Instead, they provide an opportunity to clarify information and strengthen the submission.

Manufacturers who prepare thoroughly, maintain clear documentation, and respond strategically can navigate the process efficiently.

A strong regulatory strategy—combined with well-organized technical documentation—can significantly reduce delays and improve the likelihood of successful device clearance.

Understanding how to prepare for and respond to Additional Information requests from the U.S. Food and Drug Administration is therefore an essential skill for regulatory professionals and medical device manufacturers aiming to bring safe and effective devices to the market.